Home
Acadia Pharmaceuticals ACAD spent $230K on lobbying in Q2 2023 · Medicare, Health Issues
Trade details
- Type
- Lobbying report
- Amount
- $230,000
- Quarter
- Q2 2023
- Client
- Acadia Pharmaceuticals
- Reported
- 23/07/20
Down 41.0% from last quarter
What else happened in Acadia Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 23/05/31~23/07/30Acadia Pharmaceuticals's other lobbying reports
- Acadia Pharmaceuticals
LobbyingAcadia Pharmaceuticals
LobbyingAcadia Pharmaceuticals
ACAD
$700K
$700K
Reported 07/20
for Q2
- Acadia Pharmaceuticals
LobbyingAcadia Pharmaceuticals
LobbyingAcadia Pharmaceuticals
ACAD
$80K
$80K
Reported 07/19
for Q2
- Acadia Pharmaceuticals
LobbyingAcadia Pharmaceuticals
LobbyingAcadia Pharmaceuticals
ACAD
$20K
$20K
Reported 07/10
for Q2
- Acadia Pharmaceuticals
LobbyingAcadia Pharmaceuticals
LobbyingAcadia Pharmaceuticals
ACAD
$600K
$600K
Reported 04/20
for Q1
- Acadia Pharmaceuticals
LobbyingAcadia Pharmaceuticals
LobbyingAcadia Pharmaceuticals
ACAD
$80K
$80K
Reported 04/18
for Q1